Harvard Bioscience, Inc. to Participate in The Benchmark Healthcare House Call Virtual Conference

Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be participating in the Benchmark Healthcare House Call Virtual Conference on May 22nd, 2024, with a live fireside chat scheduled for 9:00-9:40 am ET.

GlobeNewswireMay 16 16:05 ET

Harvard Bioscience | 10-Q: Quarterly report

Futu NewsMay 7 17:07 ET · Announcements

Harvard Bioscience Inc (HBIO) Q1 2024 Earnings: Challenges Persist Amidst Strategic Adjustments

Yahoo FinanceMay 7 08:41 ET

Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 EPS $0.02

07:18 AM EDT, 05/07/2024 (MT Newswires) -- Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 EPS $0.02

MT NewswiresMay 7 07:18 ET

Express News | Harvard Bioscience - Expect H2 Growth Vs Both H1 of 2024 and H2 2023, Supported by New Product Commercializations & Expected Improvements in China

ReutersMay 7 07:10 ET

Express News | Harvard Bioscience Inc - for Full Year 2024 We Expect Revenues to Be Approximately Flat Versus 2023

ReutersMay 7 07:09 ET